Reducing the Risk of Post-Surgical Cancer Recurrence: A Perioperative Anti-Inflammatory Anti-Stress Approach
Open Access
- 6 April 2018
- journal article
- research article
- Published by Taylor & Francis in Future Oncology
- Vol. 14 (11) , 1017-1021
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Surgery and stress promote cancer metastasis: New outlooks on perioperative mediating mechanisms and immune involvementBrain, Behavior, and Immunity, 2013
- COX-2 in cancer: Gordian knot or Achilles heel?Frontiers in Pharmacology, 2013
- A New Approach to Reducing Postsurgical Cancer Recurrence: Perioperative Targeting of Catecholamines and ProstaglandinsClinical Cancer Research, 2012
- Beta blockers, norepinephrine, and cancer: an epidemiological viewpointClinical Epidemiology, 2012
- Do Stress Responses Promote Leukemia Progression? An Animal Study Suggesting a Role for Epinephrine and Prostaglandin-E2 through Reduced NK ActivityPLOS ONE, 2011
- Improving Survival Rates in Two Models of Spontaneous Postoperative Metastasis in Mice by Combined Administration of a β-Adrenergic Antagonist and a Cyclooxygenase-2 InhibitorThe Journal of Immunology, 2010
- Cox-2 inactivates Smad signaling and enhances EMT stimulated by TGF- through a PGE2-dependent mechanismsCarcinogenesis, 2008
- Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trialThe Lancet, 2008
- Perioperative Use of β-blockers and COX-2 Inhibitors May Improve Immune Competence and Reduce the Risk of Tumor MetastasisAnnals of Surgical Oncology, 2008
- Models, mechanisms and clinical evidence for cancer dormancyNature Reviews Cancer, 2007